Tirzepatide Mounjaro
- Services / products
- Injection ingredients facts & info
- Tirzepatide Mounjaro
Tirzepatide is a new injectable that was recently approved by the FDA for the treatment of overweight or obesity. The weight loss injection is marketed under the brand name Mounjaro.
Its primary function is to promote weight loss by increasing satiety and reducing hunger. It does this by mimicking the action of the hormone leptin, which is responsible for regulating energy intake and expenditure. In clinical trials, Tirzepatide was shown to induce significant weight loss, with patients losing an average of 5% of their body weight after 16 weeks of treatment. Tirzepatide also resulted in improvements in blood sugar control and lipid levels. These effects are thought to be mediated by Tirzepatide’s ability to reduce inflammation and improve insulin sensitivity. Overall, Tirzepatide represents a promising new option for the treatment of obesity and related conditions.
Tirzepatide is a peptide that consists of 26 amino acids. It is produced using recombinant DNA technology in E. coli bacteria. The amino acid sequence of Tirzepatide is identical to the human GLP-1 receptor agonist peptide sequence. Tirzepatide has high affinity and selectivity for the GLP-1 receptor and potentiates cAMP accumulation in cells expressing the human GLP-1 receptor. In preclinical studies, Tirzepatide improved glucose tolerance, increased insulin secretion, and reduced body weight. In clinical trials, Tirzepatide monotherapy improved fasting plasma glucose, postprandial plasma glucose, and glycosylated hemoglobin (HbA1c) levels in individuals.
Dosing Regimen: (one shot per week)
- 10mg/100mg/mL Tirzepatide/L-Carnitine
- 30mg/100mg/mL Tirzepatide/L-Carnitine
- 40mg/100mg/mL Tirzepatide/L-Carnitine
- 50mg/100mg/mL Tirzepatide/L-Carnitine
3-MONTH SUPPLY STARTS AT $500
We strongly recommend a weekly injection of B12 for the best results, along with a healthier lifestyle modification in eating habits and excercise.
- Temporary stomach side effects such as nausea, vomiting, diarrhea, and stomach pain
- Decreased appetite
- Constipation
Other possible side effects can include: headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, retinal disorder (diabetes mellitus individuals), hypoglycemia (diabetes mellitus individuals), flatulence, gastroenteritis, GERD, gastritis, alopecia, lipase increase, amylase increase, injection site reaction, hypotension.
Serious Reactions: hypersensitivity reaction, anaphylaxis, angioedema, acute kidney injury, chronic renal failure exacerbation, pancreatitis, cholelithiasis, cholecystitis, syncope
Active Ingredients: Tirzepatide and L-Carnitine
Inactive Ingredients: Disodium phosphate dihydrate, sodium chloride, and water for injection
- Do not use Tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
- Do not use Tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Do not use Tirzepatide if you are allergic to it or any of the ingredients in Tirzepatide or Carnitine
- Allergies to shellfish
- Type 1 Diabetics
The "Skinny" on Tirzepatide with L-Carnitine
- Lowers blood sugar levels
- Signals the brain that you are full, so you eat less
- Slows the movement of food through your stomach, so you feel full longer
- Promotes weight loss; depending on the dosage, Tirzepatide can reduce an average weight loss of 20% or more in 72 weeks
- Lowers risk of heart disease
- Improves Liver health
Everyone reacts to shots differently, so finding the right one for you is key. However, please click here to see a medical review by Leigh Ann Anderson, PharmD.
